Clinical Trial: STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER)
Study Status: Completed
Recruit Status: RECRUITING
Condition: Metastatic Breast Cancer
Study Type: INTERVENTIONAL
Official Title: Phase II Study of Estradiol Therapy to Target ER-Mutant and ER-Wild-Type ER+ Metastatic or Advanced Breast Cancer
Brief Summary:
Determine whether subjects harboring ESR1-mutant/amplified breast cancer have a higher rate of clinical benefit from 17b-estradiol therapy than subjects with ESR1-wild-type breast cancer
Read more